Fifth national conference on colposcopy and cervical pathology (CSCCP)

On May 10, 2019, by China healthy birth science association colposcopy and cervical pathology branch (CSCCP), cervical cancer prevention and control research professional committee, women’s and children’s health research institute, “Chinese journal of obstetrics and gynecology clinical club, Beijing university people’s hospital, Peking University Shenzhen hospital and Beijing hosted by the department of obstetrics and gynecology at the university of the fifth session of the national colposcopy and cervical pathology (CSCCP) conference in Shenzhen convention and exhibition center grand opening.

With the theme of “promoting the fine management of cervical cancer prevention and treatment”, the conference made use of the models of academic lectures, academic thematic debates, treatment experience sharing and cervical cone cutting video competition to carry out academic exchanges and sharing, so as to strengthen the academic exchanges among fellow gynecologists, promote the development of disciplines, and build a high-level platform for the exchange of theoretical knowledge.

The conference was divided into four halls with different topics, among which Shanghai Hua Xin biotechnology co., ltd. set up the booth of “Xinfuning ® recombinant human interferon a2b vaginal vesiculation capsule” at platform B13 of exhibition stand in the exhibition center. Shenzhen LifeHealth Medical Co., Ltd., as the product partner, participated in the meeting on behalf of Shanghai hua Xin biotechnology co., LTD., All-round to the experts and scholars around the country to show the charm of the product！